Tag: cancer fusions
IDT acquires next-gen research assays from Invitae Corporation
Integrated DNA Technologies (IDT) is investing in next generation sequencing (NGS) research assays from Invitae Corporation under the trademarked name Archer.
Invitae's NGS research assays...